Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;14(7):E281-E289.
doi: 10.5489/cuaj.6697.

Canadian Urological Association Best Practice Report: Catheter use

Lysanne Campeau  1 , Samer Shamout  1 , Richard J Baverstock  2 , Kevin V Carlson  2 , Dean S Elterman  3 , Duane R Hickling  4 , Stephen S Steele  5 , Blayne Welk  6
Affiliations

Canadian Urological Association Best Practice Report: Catheter use

Lysanne Campeau et al. Can Urol Assoc J. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. Campeau has been an advisory board and speakers’ bureau member for Astellas and Pfizer; has received grants/honoraria from Allergan, Astellas, and Pfizer; and has participated in clinical trials supported by Pfizer. Dr. Baverstock has been a speaker for Allergan, Astellas, BSCI, and Pfizer; and has participated in clinical trials supported by Astellas and Pfizer. Dr. Carlson has been an advisory board member for Astellas and Pfizer; has received travel honoraria from Allergan; and has participated in clinical trials supported by Astellas and Pfizer. Dr. Elterman has been an advisory board and speakers’ bureau member for Allergan, Astellas, Boston Scientific, Duchesnay, Ferring, Medtronic, and Pfizer; has received grants/honoraria from Boston Scientific and Pfizer; and has participated in clinical trials supported by Astellas, Boston Scientific, and Medtronic. Dr. Hickling has been an advisory board member for Pfizer; a speakers’ bureau member for Allergan, Astellas, and Pfizer; has received grants/honoraria from Allergan, Astellas, and Pfizer; and has participated in clinical trials supported by Astellas. The remaining authors report no competing personal or financial interests related to this work.

References

    1. Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol. 2000;163:768–72. doi: 10.1016/S0022-5347(05)67800-7. - DOI - PubMed
    1. Nicolle LE Committee SL-TC. Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol. 2001;22:167–75. doi: 10.1086/501886. - DOI - PubMed
    1. Peatfield R, Burt A, Smith P. Suprapubic catheterization after spinal cord injury: A followup report. Paraplegia. 1983;21:220–6. doi: 10.1038/sc.1983.35. - DOI - PubMed
    1. Kiddoo D, Sawatzky B, Bascu CD, et al. Randomized crossover trial of single use hydrophilic coated vs multiple use polyvinylchloride catheters for intermittent catheterization to determine incidence of urinary infection. J Urol. 2015;194:174–9. doi: 10.1016/j.juro.2014.12.096. - DOI - PubMed
    1. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 1997;11:609–22. doi: 10.1016/S0891-5520(05)70376-7. - DOI - PubMed

LinkOut - more resources